A proven roadmap for innovation and commercialization

We empower inventors — paving pathways, clearing obstacles and dedicating significant resources to technology transfer.

Impact Dashboard

251

FY22 Invention Disclosures

79

FY22 U.S. Patents Issued

$14.6M

FY22 Licensing Revenue

7

FY22 New IP Based Startups

This is WashU Innovation

The Office of Technology Management assists WashU faculty in the transfer of technology from the lab to the global marketplace.

Explore our innovation community

researchers working in lab

A research powerhouse becomes an innovation incubator

“We believe in the idea that research can improve health outcomes, decrease health-care costs and improve the regional economy.” — David H. Perlmutter, MD, executive vice chancellor for medical affairs and the George and Carol Bauer Dean of the School of Medicine

Therapeutics

Wugen announces first patient dosed in phase 1/2 trial of WU-CART-007

March 15, 2022

Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that the first patient has been dosed in a Phase 1/2 trial of WU-CART-007 for the treatment of relapsed or refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL)/lymphoblastic lymphoma (LBL).


Announcements

Resources for Students & Alumni

The Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship serves as the primary resource for students and alumni.